Oct 27, 2016
In October 2016, clinicians and scientists from around the world gathered on the NIH campus to exchange ideas on the future of malignant peripheral nerve sheath tumor (MPNST) research. Learn more...
Over 200 people attended the first Cancer Health Disparities Interest Group Research Symposium on October 18th
Oct 25, 2016
The causes of cancer health disparities are multi-faceted and the approaches needed to understand and overcome them are multi-disciplinary. Learn more...
Oct 17, 2016
Christina Annunziata, Investigator in the Women’s Malignancies Branch, spoke with STAT about PARP inhibitors, a new class of drugs for ovarian cancer treatment. She has studied the efficacy of Lynparza, a PARP inhibitor, and says more clinical trials using PARP inhibitors with other cancer treatments will become more prevalent. Learn more...
Oct 5, 2016
Henrietta Lacks’ cells have been used around the world since the 1950s and have helped with developing the polio vaccine, gene mapping, cancer research and understanding how to grow cells in the lab. Stadtman Investigator Jadranka Loncarek from the Laboratory of Protein Dynamics and Signaling discussed how she uses HeLa cells in her research with WHAG.
Sep 27, 2016
The Swedish Minister for Higher Education & Research, Helene Hellmark Knutsson, visited CCR clinical laboratories in the NIH Clinical Center. Her visit coincided with the signing of a memorandum of understanding with the Department of Health and Human Services to encourage cooperation in promoting cancer advances and joint research opportunities between the two countries.
Sep 27, 2016
Rocky Mountain PBS will air a new documentary this Thursday, Sept. 29 at 9 p.m. called, “The answer to cancer may be walking beside us.” This documentary features Amy LeBlanc, Director of the Comparative Oncology Program, Mark Simpson, Senior Scientist in the Laboratory of Cancer Biology and Genetics, and Chand Khanna, former CCR Senior Scientist. Using animals to study cancer goes hand-in-hand with the Cancer Moonshot goals of accelerating cancer research and making more therapies available to more patients. Vice President Joe Biden, who leads the initiative, says when it comes to cancer, “Time matters. Days matter. Minutes matter.”